Back to Search
Start Over
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
- Source :
- Arthritis Research & Therapy; 1/5/2022, Vol. 24 Issue 1, p1-15, 15p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 14786354
- Volume :
- 24
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Arthritis Research & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 154501540
- Full Text :
- https://doi.org/10.1186/s13075-021-02709-2